TAM
FBT icon

Titleist Asset Management’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Titleist Asset Management’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$412K Sell
1,662
-25
-1% -$5.38K 0.03% 300
2026
Q1 		$339K Buy
1,687
+30
+2% +$6.21K 0.03% 309
2025
Q4 		$342K Buy
+1,657
New +$331K 0.03% 287

Other funds holding FBT

NP
Nilsine Partners Greenwood Village, Colorado $1.45B AUM 47.06% 1-Year Est. Return
DADC
D.A. Davidson & Co Great Falls, Montana $18.1B AUM 24.63% 1-Year Est. Return
BEI
Benjamin Edwards Inc Clayton, Missouri $11B AUM 18.22% 1-Year Est. Return
HFM
Hartford Financial Management Hartford, Connecticut $448M AUM 32.11% 1-Year Est. Return
AFA
Arlington Financial Advisors Santa Barbara, California $787M AUM 22.93% 1-Year Est. Return
IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
HFP
Holistic Financial Partners Indianapolis, Indiana $164M AUM 32.79% 1-Year Est. Return
JWS
Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return
TWM
TriaGen Wealth Management Calabasas, California $400M AUM 39.13% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return

Titleist Asset Management's FBT Position: Q2 2026 in Review

Titleist Asset Management reduced its First Trust NYSE Arca Biotechnology Index Fund (FBT) stake by 1.5% in Q2 2026, selling an estimated $5.38K and leaving 1,662 shares worth $412K. The position accounts for 0.03% of the portfolio, ranked #300.

Titleist Asset Management first reported a position in FBT in Q4 2025 and has held it in 3 quarters since. 92 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Titleist Asset Management held 1,662 shares of First Trust NYSE Arca Biotechnology Index Fund worth $412K as of Q2 2026.
  • Titleist Asset Management sold 25 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $5.38K.
  • First Trust NYSE Arca Biotechnology Index Fund made up 0.03% of Titleist Asset Management's portfolio in Q2 2026, its #300 holding.
  • Titleist Asset Management first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q4 2025 and has held it in 3 quarters since.
  • 92 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Titleist Asset Management's 13F filing for Q2 2026, filed 20 Jul 2026.